Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Pediatrics/Neonatology  |  Vaccines

Search Medical Condition
Please enter condition
Please choose location from dropdown

Vaccines Clinical Trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (864) clinical trials

Study of an Investigational vaccine against Pneumonia  

Phase

This is a study for an investigational vaccine for Hepatitis B.

Phase

Optimal Research is now enrolling healthy adults ages 60 & older for a 2-year research study for RSV. All study-related care is provided at no cost. Compensation may be provided to qualified participants up to $1725.00. Visit us to learn more: www.optimalsites.net/RSV

Phase N/A

A research study is evaluating an investigational medication compared to Tamiflu® for pediatric patients showing flu-like symptoms starting within the last 48 hours.  

Phase N/A

A research study is comparing an investigational plant-based vaccine to an FDA-approved quadrivalent vaccine for influenza (flu).

Phase N/A

Meningococcal meningitis is a serious illness that can occur at any age. It affects the covering of the brain and spinal cord. It can also result in blood infection. Vaccination is the best way to prevent meningococcal disease.

Phase

A research study is evaluating an investigational quadrivalent meningococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants.

Phase N/A

A research study is evaluating an investigational pneumonia vaccine compared to an FDA-approved comparator vaccine.

Phase N/A

This study will evaluate the safety, pharmacokinetics, and efficacy of baloxavir marboxil compared with oseltamivir in a single influenza episode in otherwise healthy pediatric participants (i.e., 1 to <12 years of age) with influenza-like symptoms.

Phase

This study aims to determine the HEPLISAV-B hepatitis B vaccine efficacy in chronic lymphocytic leukemia (CLL) patients that are treatment naive or receiving Bruton s-tyrosine kinase inhibitor (BTK-I) therapy. Key Eligibility Criteria: Diagnosis of CLL Cohort 1: Treatment naive CLL patients Cohort 2: Subjects must be receiving ibrutinib monotherapy for ...

Phase N/A